Challenges Facing the Pharmaceutical Industry
The webinar "Challenges Facing the Pharmaceutical Industry" organized by ChemistryViews.org will take place on Thursday March 27, 2014 at 8:00 PDT | 11:00 EDT | 15:00 UK | 16:00 CET.
John LaMattina, former President, Pfizer Global R&D, discusses how and why the pharma industry is devalued and distrusted.
Topics covered in the webinar are:
a) Challenges facing the industry: establishing the safety AND value of new drugs;
b) Issues facing the Industry on its reputation;
c) A prescription form restoring its reputation.
John La Mattina is a Senior Partner at PureTech Health and author of the books:
Drug Truths: Dispelling the Myths About Pharma R&D and Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image?
Please follow this link to register for the webinar.
most read
BASF Sells Majority Stake in Coatings Business
BASF sells a majority stake in its coatings business to the investor Carlyle.
Novo Nordisk to Cut 9,000 Jobs Globally in Major Restructuring
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
Merck Acquires Chromatography Business from JSR Life Sciences
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
VCI Welcomes US-EU Customs Deal
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.